Evidence map›Paper›PMID 40390095›Full record

ArticleGenome medicine2025

RNA polymerase I is essential for driving the formation of 3D genome in early embryonic development in mouse, but not in human.

Changliang Hou, Geng G Tian, Shuanggang Hu, Beili Chen, Xiaoyong Li, Bo Xu, Yuedi Cao, Wei Le, Rong Hu, Hao Chen and 16 more

Abstract read
In one paragraph

Article in Genome medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Changliang Hou *Key Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Geng G Tian *Key Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. genetian@sjtu.edu.cn.
Shuanggang Hu *Center for Reproductive Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200135, China.
Beili Chen *Department of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Xiaoyong Li *Key Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Bo Xu *Key Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yuedi Cao *Key Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wei LeDepartment of Urology, Tongji Hospital, Tongji University School of Medicine, 389 Xincun Road, Shanghai, China.
Rong HuNingxia Key Laboratory of Clinical and Pathogenic Microbiology, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China.
Hao ChenInstitute of Reproductive Medicine, Medical School of Nantong University, Nantong, China.
Yan ZhangNational Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Qian FangKey Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Man ZhangLaboratory Animal Center, Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China.
Zhaoxia WangLaboratory Animal Center, Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China.
Zhiguo ZhangDepartment of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Jinfu ZhangDepartment of Reproductive Medicine, Guanghua HospitalAffiliated to, Shanghai University of Traditional Chinese Medicine , 540 Xinhua Road, Shanghai, China.
Zhaolian WeiDepartment of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Guangxin YaoCenter for Reproductive Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200135, China.
Yefan WangSheng Yushou Center of Cell Biology and Immunology , School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Ping YinShuguang Hospital affiliated to, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ya GuoSheng Yushou Center of Cell Biology and Immunology , School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China.
Guoqing TongDepartment of Reproductive Medicine, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China. drivftongguoqing@xjtufh.edu.cn.
Xiaoming TengDepartment of Assisted Reproduction, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. tengxiaoming@51mch.com.
Yun SunCenter for Reproductive Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200135, China. syun163@163.com.
Yunxia CaoDepartment of Obstetrics and Gynecology, Reproductive Medicine Center, The First Affiliated Hospital of Anhui Medical University, Hefei, China. caoyunxia6@126.com.
Ji WuKey Laboratory for the Genetics of Developmental & Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. jiwu@sjtu.edu.cn.

Funding

National Key Research and Development Program of China 2022YFA0806301National Nature Science Foundation of China 82201780the Scientific and Technological Innovation Action program of Shanghai 23JC1402800
6 · The paper itself

Abstract

backgroundThree-dimensional (3D) chromatin architecture undergoes dynamic reorganization during mammalian gametogenesis and early embryogenesis. While mouse studies have shown species-specific patterns as well as mechanisms underlying de novo organization, these remain poorly characterized in humans. Although RNA polymerases II and III have been shown to regulate chromatin structure, the potential role of RNA polymerase I (Pol I), which drives ribosomal RNA production, in shaping 3D genome organization during these developmental transitions has not been investigated.

methodsWe employed a modified low-input in situ Hi-C approach to systematically compare 3D genome architecture dynamics from gametogenesis through early embryogenesis in human and mouse. Complementary Smart-seq2 for low-input transcriptomics, CUT&Tag for Pol I profiling, and Pol I functional inhibition assays were performed to elucidate the mechanisms governing chromatin organization.

resultsOur study revealed an extensive reorganization of the 3D genome from human oogenesis to early embryogenesis, displaying significant differences with the mouse, including dramatically attenuated topologically associating domains (TADs) at germinal vesicle (GV) stage oocytes. The 3D genome reconstruction timing is a fundamental difference between species. In human, reconstruction initiates at the 4-cell stage embryo in human, while in mouse, it commences at the 2-cell stage embryo. We discovered that Pol I is crucial for establishing the chromatin structures during mouse embryogenesis, but not in human embryos. Intriguingly, the absence of Pol I transcription weakens TAD structure in mouse female germline stem cells, whereas it fortifies it in human counterparts.

conclusionsThese observed interspecies distinctions in chromatin organization dynamics provide novel insights into the evolutionary divergence of chromatin architecture regulation during early mammalian development. Our findings provide mechanistic insights into species-specific chromatin organization during germ cell and embryonic development and have potential implications for fertility preservation and birth defect prevention.

Indexed as

Embryonic DevelopmentGenomeRNA Polymerase IAnimalsChromatinFemaleGene Expression Regulation, DevelopmentalHumansMiceOocytesChromatinRNA Polymerase IChromatin structureEarly embryonic developmentPolymerase IStem cell

Identifiers

PMID40390095
PMCPMC12087037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.